T 0349/91 of 10.03.1993
- European Case Law Identifier
- ECLI:EP:BA:1993:T034991.19930310
- Date of decision
- 10 March 1993
- Case number
- T 0349/91
- Petition for review of
- -
- Application number
- 81900044.9
- IPC class
- A61K 39/00G01N 33/577G01N 33/574
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Monoclonalhybridoma antibody specific for high molecular weight carcinoembryonic antigen
- Applicant name
- The Wistar Institute
- Opponent name
- F. Hoffmann-La Roche & Co. Aktiengesellschaft
- Board
- 3.4.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54 1973European Patent Convention Art 56 1973European Patent Convention Art 83 1973
- Keywords
- Sufficient disclosure - no; rectified by amendment of claims
Novelty (yes)
Inventive step (yes) - Catchword
- -
- Cited cases
- -
ORDER
For these reasons, it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the Opposition Division with the order to maintain the patent on the basis of Claims 1 to 4 of alternative (auxiliary) request 2 and description to be adapted.